Does reduction in cardiovascular death account for the increase in ESRD? An examination of the 'competing mortality' hypothesis.

被引：0
|
作者：
Levy, EM
Meltzer, D
机构：
[1] BRIGHAM & WOMENS HOSP, DIV RENAL, BOSTON, MA 02115 USA
[2] BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A0733 / A0733
页数：1
相关论文
共 50 条
  • [41] Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Investigators Reports that Symptomatic Severe Hypoglycaemia does not Account for the Excess Mortality in the Intensively Treated Arm of Their Study
    不详
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 263 - 263
  • [42] Domain Led Time Series Analysis Of Cardiovascular Disease Using Open Data - Does Reduction in Coronary Disease Increase Heart Failure Prevalence?
    Jasinska-Piadlo, Alicja
    Bond, Raymond
    Biglarbeigi, Pardis
    Campbell, Patricia
    McEneaney, D.
    2021 COMPUTING IN CARDIOLOGY (CINC), 2021,
  • [43] Does the association between socioeconomic status and cause-specific mortality vary by race? An examination of cardiovascular disease and breast cancer mortality among African-American and White women.
    Kim, C
    Eby, E
    Piette, J
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 146 - 146
  • [44] DOES PROSTATE CANCER REPRESENT THE MAIN CAUSE OF DEATH IN ALL NODE POSITIVE PROSTATE CANCER PATIENTS? THE IMPACT OF COMPETING CAUSES OF MORTALITY ACCORDING TO TUMOR CHARACTERISTICS AND RECURRENCE STATUS
    Dell'Oglio, Paolo
    Zaffuto, Emanuele
    Stabile, Armando
    Gandaglia, Giorgio
    Colicchia, Michele
    Fossati, Nicola
    Capitanio, Umberto
    Deho, Federico
    Colombo, Renzo
    Bertini, Roberto
    Montorsi, Francesco
    Karnes, R. Jeffrey
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2017, 197 (04): : E57 - E57
  • [45] Does the southern European cardiovascular mortality advantage extend to total mortality? 50-year trends in death risks between 40 and 70 years of age in Western European men and women
    Vollset, Stein Emil
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2010, 38 : 127 - 134
  • [46] Treatment of Anaemia with Erythropoiesis-Stimulating Agents in Patients with Chronic Kidney Disease Does Not Lower Mortality and May Increase Cardiovascular Risk: A Meta-Analysis
    Vinhas, J.
    Barreto, C.
    Assuncao, J.
    Parreira, L.
    Vaz, A.
    NEPHRON CLINICAL PRACTICE, 2012, 121 (3-4): : C95 - C101
  • [47] Does Abdominal Obesity Increase All-Cause, Cardiovascular Disease, and Cancer Mortality Risks in Older Adults? A 10-Year Follow-Up Analysis
    Nogueira E Moura, Leticia de Almeida
    Pagotto, Valeria
    Pereira, Cristina Camargo
    de Oliveira, Cesar
    Silveira, Erika Aparecida
    NUTRIENTS, 2022, 14 (20)
  • [48] Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages
    Ooi, Seng-Wei
    Yeh, Shu-Tin
    Chang, Ya-Hui
    Li, Chung-Yi
    Chen, Hua-Fen
    PLOS ONE, 2022, 17 (08):
  • [49] Activity-to-sedentary ratio provides novel insight into mortality reduction among male survivors of cardiovascular disease in the United States: national health and nutrition examination survey, 2007–2014
    Yuanyuan Ding
    Jiahao Chen
    Mengying Niu
    Qi Xiao
    Hongqin Zhao
    Xudong Pan
    Xiaoyan Zhu
    BMC Public Health, 23
  • [50] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Gerstein, Hertzel C.
    Swedberg, Karl
    Carlsson, Jonas
    McMurray, John J. V.
    Michelson, Eric L.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Yusuf, Salim
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1699 - 1704
12345